Antipsychotic drugs and safety concerns for breast-feeding infants

Tapan Parikh, Dharmendra Goyal, Jonathan R. Scarff, Steven Lippmann*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations

Abstract

Antipsychotic drugs prescribed to treat psychiatric symptoms during the postpartumperiod are secreted into breastmilk. Because breast-feeding is crucial to infant development, it is important to select a medication that poses the fewest adverse consequences. Aripiprazole, haloperidol, perphenazine, and trifluoperazine demonstrate no known developmental dangers. Olanzapine, quetiapine, and risperidone are cited as safe, although monitoring is recommended. Chlorpromazine and clozapine may induce developmental concerns. There are limited safety data for asenapine, fluphenazine, iloperidone, loxapine, lurasidone, paliperidone, pimozide, thioridazine, thiothixene, and ziprasidone. Clinicians should choose medications considered to be the safest and prescribe them at the lowest effective doses

Original languageEnglish (US)
Pages (from-to)686-688
Number of pages3
JournalSouthern Medical Journal
Volume107
Issue number11
DOIs
StatePublished - 2014
Externally publishedYes

Keywords

  • Antipsychotic drugs
  • Atypical antipsychotic medications
  • Breast-feeding
  • Lactation
  • Typical antipsychotic agents

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Antipsychotic drugs and safety concerns for breast-feeding infants'. Together they form a unique fingerprint.

Cite this